Company filings on SEC EDGAR · Form 8-K/A (amended current report)
8-K/A - Mereo BioPharma Group plc
Mereo BioPharma Group plc filed an amended Form 8-K (Form 8-K/A) with the U.S. Securities and Exchange Commission on May 12, 2026. A Form 8-K discloses a material corporate event; it is a company filing, not an enforcement action.
Read the official source on sec.gov →
- Issued by
- Mereo BioPharma Group plc, filed with the U.S. Securities and Exchange Commission
- Document type
- Form 8-K/A (amended current report)
- Date
- First recorded by CourtPulse
- · all records that day
- Company
- Mereo BioPharma Group plc · SEC CIK 1719714
CourtPulse lists public records with a link to the official source. The title is shown as the source published it; this page adds no commentary.